NCT05198141View on ClinicalTrials.gov

Evaluation of Different Doses of Letrozole in Ectopic Pregnancy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

November 20, 2021

Study Completion Date

January 1, 2022

Conditions
Ectopic Pregnancy
Interventions
DRUG

Letrozole tablets

GI: Patients who were undergoing laparoscopic salpingectomy GII: patients who medically treated with 5 mg d-1 of letrozole using two tablets (2.5 mg of Femara) every day for 10 d GIII patients who medically treated with 10 mg d-1 of letrozole using four tablets (2.5 mg of Femara) every day for 10 d (group III)

PROCEDURE

laparoscopic salpingectomy

laparoscopic salpingectomy

Trial Locations (1)

14150

Mohamed ALI Alabiad, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05198141 - Evaluation of Different Doses of Letrozole in Ectopic Pregnancy | Biotech Hunter | Biotech Hunter